Enwei Pharmaceutical Co., Ltd. (SHE:301331)
21.84
+0.24 (1.11%)
At close: Sep 30, 2026
| Market Cap | 2.22B -31.1% |
| Revenue (ttm) | 826.13M -5.4% |
| Net Income | 29.62M -48.8% |
| EPS | 0.28 -51.1% |
| Shares Out | 101.88M |
| PE Ratio | 77.13 |
| Forward PE | n/a |
| Dividend | 1.03 (4.72%) |
| Ex-Dividend Date | May 28, 2026 |
| Volume | 1,136,542 |
| Open | 21.61 |
| Previous Close | 21.60 |
| Day's Range | 21.60 - 22.06 |
| 52-Week Range | 18.87 - 33.50 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 26, 2026 |